1Martinez FD,Wright AL,Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med, 1995,332(3) : 133.
2Politiek MJ, Boorsma M, Aalbers R. Comparison of formoterol,salbutamol and salmeterol in methacholine-induced severe bronchoconstriction. Ettr Respir J, 1999,13 (5) :988.
3Goodman LS, Gilman A. The pharmacological basis of therapeutics.9th ed. New York,NY: Mc Gram-Hill Book Co, 1996.1459.
4Global Initiative For Asthma. National institutes of health. National Heart, Lung, and Blood Institute, Revised,2002.105.
5Harding SM.The human pharmacology of fluticasone propionate.Respir Med,1990,84(suppl A):25—29.
6Falcoz C,Mackie AE,McDowall J,et a1.Oral bioavailability of fluticasone propionate in healthy subjects.Br J Clin Pharmacol,1996,41:459—460.
7Hoekx JC,Hedlin G,Pedesen W,et a1.Fluticasone propionate compared budesonide:A double.blind trial in asthmatic children using powder devices at a dosage of 400 microg×day(-1).Eur Respir J,1996,9(11):2263—2272.
8Allen DB,Bronskg EA,Lafone CF,et al.Fluticasone Propionate Asthma Study Group.Growth in asthmatic children treated with fluticasone propionate.J Pediatr,1998,132(3 Pt 1):472—477.
9Price JF.Russenll G,Hindmarsh PC,et a1.Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma.Pediatr Pulmonol.1997,24(3):178—186.
